Glycoconjugation: An approach to cancer therapeutics

Maria I Molejon1, Gisela Weiz1, Javier D Breccia1

  • 1Institute of Earth and Environmental Sciences from La Pampa (INCITAP), National University of La Pampa, School of Natural Sciences (CONICET-UNLPam), Santa Rosa 6300, La Pampa, Argentina.

Insights

Glycosylation enhances antitumor drugs for gastrointestinal tumors, improving drug delivery and reducing side effects. This review explores how glycosylated drugs target tumors, offering new therapeutic options.

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Delivery

Background:

  • Cancer is a leading global cause of death, with limited treatment options for advanced gastrointestinal tumors.
  • Current therapies for gastrointestinal tumors are effective only for a small patient subset at diagnosis.
  • Novel therapeutic strategies are crucial for managing advanced-stage gastrointestinal cancers.

Purpose of the Study:

  • To review the impact of glycosylation on antitumor agents for gastrointestinal tumors.
  • To examine the tumor-targeting capabilities of glycosylated drugs.
  • To assess the potential of glycosylated antitumor agents in improving treatment outcomes.

Main Methods:

  • Literature review of studies on glycosylated antitumor agents.
  • Analysis of pharmacokinetic and pharmacodynamic properties of glycodrugs.
  • Evaluation of targeting efficiency in gastrointestinal tumor models.

Main Results:

  • Glycosylation improves drug pharmacokinetic profiles, including half-life and reduced side effects.
  • Glycosylated antitumor agents demonstrate enhanced targeting of gastrointestinal tumor tissues.
  • Reduced drug dosages are feasible with glycosylated agents due to improved targeting.

Conclusions:

  • Glycosylation is a promising strategy for developing effective antitumor agents against gastrointestinal tumors.
  • Targeted delivery of glycosylated drugs offers a potential advantage in cancer therapy.
  • Further research into glycosylated antitumor agents could lead to improved patient outcomes.

Related Concept Videos

Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
9.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
872
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
26.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K